Work

Impact of infusion time on post–CAR T-cell survival in B-ALL

Year: 2026

Type: article

Source: Blood Immunology & Cellular Therapy

DOI: 10.1016/j.bict.2026.100087

Authors: Chelsea Lamplugh, Mark L. Solter, Alexandra Dreyzin, Kathryn Martin, Steve L. Highfill, David Stroncek, Nirali N. Shah

Institutions: National Institutes of Health, Johns Hopkins University, Johns Hopkins Children's Center, National Cancer Institute, Center for Cancer Research, Johns Hopkins Hospital, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, National Institutes of Health Clinical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: U.S. Department of Health and Human Services, Swedish Orphan Biovitrum, National Institutes of Health, National Cancer Institute, NIH Clinical Center

Awards: G5895579807, Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies

OpenAlex ID: W7211879675

FWCI:

Cites:

Cited by:

Related to: